Abstract

1044P - Pembrolizumab in patients with MSI-H advanced endometrial cancer from the KEYNOTE-158 study

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call